ConductScience.org, home
An Extension Study to Evaluate the Safety and Tolerability of Ranibizumab in Subjects With Choroidal Neovascularization Secondary to AMD or Macular Edema Secondary to RVO
API referenceFor AI assistants

Trial · NCT00379795

Participant flow20

How many started, completed or left each group, period by period.

1 to 20 of 20

Download this page as JSON
PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTEDRanibizumabTreated Initial Mono526
Overall StudySTARTEDRanibizumabTreated Initial + PDT74
Overall StudySTARTEDRanibizumabTreated Sham XO116
Overall StudySTARTEDRanibizumab Treated PDT XO74
Overall StudySTARTEDRanibizumab Untreated Group63
Overall StudyReceived Ranibizumab in Extension StudyRanibizumabTreated Initial Mono377
Overall StudyReceived Ranibizumab in Extension StudyRanibizumabTreated Initial + PDT41
Overall StudyReceived Ranibizumab in Extension StudyRanibizumabTreated Sham XO113
Overall StudyReceived Ranibizumab in Extension StudyRanibizumab Treated PDT XO55
Overall StudyReceived Ranibizumab in Extension StudyRanibizumab Untreated Group0
Overall StudyCOMPLETEDRanibizumabTreated Initial Mono50
Overall StudyCOMPLETEDRanibizumabTreated Initial + PDT23
Overall StudyCOMPLETEDRanibizumabTreated Sham XO23
Overall StudyCOMPLETEDRanibizumab Treated PDT XO6
Overall StudyCOMPLETEDRanibizumab Untreated Group14
Overall StudyNOT COMPLETEDRanibizumabTreated Initial Mono476
Overall StudyNOT COMPLETEDRanibizumabTreated Initial + PDT51
Overall StudyNOT COMPLETEDRanibizumabTreated Sham XO93
Overall StudyNOT COMPLETEDRanibizumab Treated PDT XO68
Overall StudyNOT COMPLETEDRanibizumab Untreated Group49

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00379795/flow

API referenceFor AI assistants